RhumbLine Advisers’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.46M | Buy |
77,384
+13,011
| +20% | +$749K | ﹤0.01% | 1472 |
|
|
2025
Q1 | $3.75M | Buy |
64,373
+3,077
| +5% | +$179K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $4.94M | Buy |
61,296
+3,242
| +6% | +$261K | ﹤0.01% | 1428 |
|
|
2024
Q3 | $4.65M | Sell |
58,054
-3,818
| -6% | -$306K | ﹤0.01% | 1468 |
|
|
2024
Q2 | $3.78M | Buy |
61,872
+5,793
| +10% | +$354K | ﹤0.01% | 1544 |
|
|
2024
Q1 | $2.77M | Buy |
56,079
+1,541
| +3% | +$76.2K | ﹤0.01% | 1740 |
|
|
2023
Q4 | $2.29M | Buy |
54,538
+5,023
| +10% | +$211K | ﹤0.01% | 1836 |
|
|
2023
Q3 | $1.62M | Buy |
49,515
+1,971
| +4% | +$64.7K | ﹤0.01% | 1959 |
|
|
2023
Q2 | $1.68M | Buy |
47,544
+12,957
| +37% | +$458K | ﹤0.01% | 2004 |
|
|
2023
Q1 | $982K | Buy |
34,587
+795
| +2% | +$22.6K | ﹤0.01% | 2126 |
|
|
2022
Q4 | $1.4M | Buy |
33,792
+1,308
| +4% | +$54.3K | ﹤0.01% | 1970 |
|
|
2022
Q3 | $1.35M | Buy |
32,484
+2,624
| +9% | +$109K | ﹤0.01% | 1982 |
|
|
2022
Q2 | $976K | Buy |
29,860
+22,634
| +313% | +$740K | ﹤0.01% | 2153 |
|
|
2022
Q1 | $253K | Buy |
+7,226
| New | +$253K | ﹤0.01% | 2691 |
|